A complete application in a minute
Tailored resume and cover letter, ready to send.
Celea Therapeutics in the United States seeks an accomplished senior clinical development leader to shape and execute late-stage programs in serious respiratory diseases, partnering with CRO teams on study design, safety reviews and regulatory deliverables.
Candidates should hold an advanced degree and 8+ years in clinical development, with CRO oversight, GCP familiarity and an entrepreneurial mindset plus AI-tool proficiency. Compensation includes a salary of $225k–$240k plus bonus and equity.
Celea Therapeutics is a biopharmaceutical company dedicated to advancing transformative treatments for serious respiratory diseases, with its lead program in Phase 3 clinical development. As an early-stage, mission-driven team, Celea values accountability, transparency, collaboration, innovation, and passion.